IL6 and COVID-19: Notably, in one patient with obviously elevated IL‐6 at baseline, IL‐6 was markedly decreased, while the clinical presentation was aggravated and disease exacerbation was later proven to be caused by bacterial infection, which may also suggest the potential value of IL‐6 in monitoring severe COVID‐19.